Apogee Therapeutics, Inc.
APGE
$44.48
$2.626.26%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -37.11% | 31.66% | 24.40% | 440.68% | 477.50% |
Total Receivables | -- | 286.90% | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 53.96% | 50.98% | 51.44% | 80.19% | 984.62% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -78.46% | -- | -71.93% | -22.25% | 414.18% |
Total Current Assets | -36.45% | 32.96% | 25.34% | 421.82% | 477.82% |
|
|||||
Total Current Assets | -36.45% | 32.96% | 25.34% | 421.82% | 477.82% |
Net Property, Plant & Equipment | 548.53% | 413.65% | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1,730.17% | 24.19% | -- | -- | -- |
Total Assets | -13.29% | 87.83% | 82.05% | 512.75% | 479.97% |
|
|||||
Total Accounts Payable | -43.17% | -50.02% | 83.44% | -50.42% | 345.80% |
Total Accrued Expenses | 64.76% | 40.09% | 72.37% | 169.18% | 57.47% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 248.47% | 193.73% | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 52.94% | 38.92% | 89.84% | 39.75% | 92.52% |
|
|||||
Total Current Liabilities | 52.94% | 38.92% | 89.84% | 39.75% | 92.52% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1,144.44% | 821.44% | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 83.94% | 72.90% | 143.82% | 53.38% | 98.15% |
|
|||||
Common Stock & APIC | 7.94% | 103.00% | 93.52% | 42,708.00% | 42,437.49% |
Retained Earnings | -131.78% | -147.16% | -159.36% | -166.42% | -197.96% |
Treasury Stock & Other | 706.78% | 178.12% | 2,322.22% | -106.38% | -105.18% |
Total Common Equity | -15.98% | 88.67% | 79.45% | 1,301.02% | 1,818.32% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -15.98% | 88.67% | 79.45% | 1,301.02% | 1,818.32% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -15.98% | 88.67% | 79.45% | 584.32% | 512.64% |
|